BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, January 18, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Appointments and advancements for July 22, 2020

July 22, 2020
New hires and promotions in the med-tech industry, including: Iqvia Holdings, Myriad Genetics.
Read More

Regulatory actions for July 22, 2020

July 22, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aurinia, AGTC, Jazz, MC2, Redhill.
Read More

Other news to note for July 22, 2020

July 22, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adaptvac, Akcea, Almirall, Altimmune, Ampio, Astellas, ATAI, Bavarian Nordic, Biofourmis, Chugai, Covaxx, Cullinan, Daiichi Sankyo, ERC, Evotec, Fibrogenesis, Innovation, Ionis, Jaguar, Kiadis, Liminal, Nouscom, Novartis, Oragenics, Q Biomed, Qualigen, Scynexis, Therapeutics Solutions, Xbiotech, Zynerba.
Read More

In the clinic for July 22, 2020

July 22, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Ascentage, Azurrx, Axogen, Belite, Genentech, Horizon, Regulus, Scynexis, Springworks, Talaris, Terns, TG, Transgene, Valneva.
Read More

Financings for July 22, 2020

July 22, 2020
Biopharmas raising money in public or private financings, including: 4D, Alx, CASI, Cytokinetics, Eikonoklastes, Genocea, GT Biopharma, Kiniksa, Olema, Resverlogix, Vesigen.
Read More

Appointments and advancements for July 22, 2020

July 22, 2020
New hires and promotions in the biopharma industry, including: Adaptate, Aztherapies, Biogen, Cellectis, Dynavax, Generation, Replimune.
Read More

Earnings for July 22, 2020

July 22, 2020
Quarterly snapshots from biopharma companies with marketed products, including: Biogen.
Read More

Clinical data for July 14-20, 2020

July 21, 2020
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Akebia, Algernon, Ascletis, Astrazeneca, Bioarctic, Biogen, Biontech, Calcimedica, Celltrion, China National, Dynavax, Eisai, Glaxosmithkline, Heron, Medicago, Moderna, Neurorx, Pfizer, Phasebio, Relief, Ribomic, Rigel, Santen, Synairgen.
Read More

Regulatory actions for July 14-20, 2020

July 21, 2020
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Astellas, Beigene, Deciphera, Generex, Immuron, IMV, Puma, Redhill, Shanghai Fosun, Sorrento, Specialised, Tetra.
Read More

Financings for July 21, 2020

July 21, 2020
Biopharmas in Asia-Pacific raising money in public or private financings, including: Arctic Vision, Beigene, Eisai, Exalys, Sosei.
Read More
Previous 1 2 … 1512 1513 1514 1515 1516 1517 1518 1519 1520 … 1738 1739 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 16, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 16, 2026.
  • SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

    BioWorld Science
    Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
  • Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

    BioWorld
    With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
  • Illustration of human body surrounded by DNA, cell and drug icons

    Cell/gene therapy sector now sustainable; China competition mounting

    BioWorld
    There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing